Page last updated: 2024-11-04

suramin and Leukemia P388

suramin has been researched along with Leukemia P388 in 1 studies

Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years.

Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barret, JM1
Ernould, AP1
Rouillon, MH1
Ferry, G1
Genton, A1
Boutin, JA1

Other Studies

1 other study available for suramin and Leukemia P388

ArticleYear
Studies of the potency of protein kinase inhibitors on ATPase activities.
    Chemico-biological interactions, 1993, Volume: 86, Issue:1

    Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Apyrase; Cell Membrane; Chromatography,

1993